![]() |
市場調查報告書
商品編碼
1452614
南美洲和中美洲深腦模擬市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶South & Central America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User |
南美洲和中美洲深部腦部模擬市場預計將從2022年的2,753萬美元成長到2030年的5,095萬美元。預計2022年至2030年CAGR為8.0%。
對微創手術的需求不斷成長推動南美洲和中美洲深部腦部模擬市場
深部腦部刺激是一種微創標靶手術,用於治療肌張力失調、帕金森氏症和特發性震顫等運動障礙。微創手術 (MIS) 與傳統手術技術相比具有多種優勢。 MIS 可最大程度地減少對身體的創傷,減少術後疼痛,提高恢復速度並改善結果。機器人手術代表了微創手術的最新發展,為外科醫生提供了使用與傳統腹腔鏡檢查相同的小切口的精密設備。與開放性手術相比,MIS 可以減少失血量、減少止痛劑的使用、縮短術後住院時間。此外,微創手術比傳統手術方法的準確率更高。此外,這些手術需要足夠大的微小切口來插入細管和相機。 MIS 的這些好處正在增加住院患者的數量,並鼓勵面臨高手術發病率和死亡率的老年患者尋求手術。因此,微創手術因其優勢而不斷成長的需求促進了南美洲和中美洲深部腦部刺激(DBS)市場的成長。
南美洲和中美洲深腦模擬市場概述
在巴西,人口老化正在迅速成長。根據泛美衛生組織(PAHO)的資料,巴西60歲以上人口超過3,000萬,佔全國人口的13%。到 2030 年,這一年齡層的人口預計將達到約 5,000 萬,佔巴西人口的 24%。根據巴西統計局的數據,到2050年,該國65歲及以上的人口預計將佔巴西總人口的36%。此外,神經系統疾病的盛行率取決於巴西的老年人口;因此,帕金森氏症和阿茲海默症等神經系統疾病發病率的增加可能會推動對深部腦部刺激(DBS)治療的需求。此外,根據2023 年發表的研究《2000-2019 年巴西阿茲海默症死亡率趨勢》,在巴西,由於人口日益老化,加上死亡率不斷上升,阿茲海默症已成為一個主要的健康問題以及該疾病在該國日益普及。 2009年至2019年間,該國因阿茲海默症死亡的人數增加了49%,使其成為第七大死因。巴西同期有超過 211,600 人死於該疾病。此外,73%的死亡人數為80歲以上,27%為60-79歲年齡層。因此,預計上述因素將在未來幾年增加該國對 DBS 設備用於治療疾病的需求。
南美洲和中美洲深腦模擬市場收入及 2030 年預測(百萬美元)
南美洲和中美洲深腦模擬市場細分
南美洲和中美洲深腦模擬市場分為產品、應用、最終用戶和國家。
根據產品,南美洲和中美洲深部腦模擬市場分為單通道深部腦部刺激器、雙通道深部腦部刺激器以及軟體和配件。 2022年,雙通道深部腦部刺激器細分市場在中南美洲深部腦部模擬市場中佔據最大佔有率。
根據應用,南美洲和中美洲深部腦模擬市場分為帕金森氏症、震顫、肌張力失調、癲癇、阿茲海默症等。 2022年,帕金森氏症領域在南美洲和中美洲深部腦部模擬市場中佔據最大佔有率。
根據最終用戶,南美洲和中美洲深部腦部模擬市場分為醫院、神經科診所、門診手術中心等。 2022年,醫院領域在南美洲和中美洲深部腦部模擬市場中佔據最大佔有率。
根據國家/地區,南美洲和中美洲深腦模擬市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022年,巴西在南美洲和中美洲深部腦部模擬市場中佔據最大佔有率。
雅培 (Abbott)、美敦力 (Medtronic)、波士頓科學 (Boston Sci) 和 Leva Nova 是南美洲和中美洲深腦模擬市場的一些領先公司。
The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in 2022 to US$ 50.95 million by 2030. It is estimated to grow at a CAGR of 8.0% from 2022 to 2030.
Increasing Demand for Minimally Invasive Surgery Drive South & Central America Deep Brain Simulation Market
Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson's disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Robotic procedures represent the latest evolution in minimally invasive procedures, providing surgeons with precision equipment that uses the same small incisions used in traditional laparoscopy. MIS leads to less blood loss, less analgesic use, and shorter postoperative hospital stay than open surgery. In addition, minimally invasive surgery indicates a higher accuracy rate than traditional surgical methods. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Thus, the rising demand for minimally invasive surgeries due to their advantages bolsters the South & Central America deep brain stimulation (DBS) market growth.
South & Central America Deep Brain Simulation Market Overview
In Brazil, the aging population is rapidly growing. According to the data from Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and older, representing 13% of the country's population. By 2030, this age group is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazil Statistical Institute, the country's population aged 65 and above is expected to hold 36% share of the total population of Brazil by 2050. Further, the prevalence of neurological disorders is dependent on the geriatric population in Brazil; thus, the increasing incidences of neurological diseases, such as Parkinson's disease and Alzheimer's disease, are likely to propel the demand for deep brain stimulation (DBS) for treatment. Moreover, as per the study, "Trends in mortality from Alzheimer's disease in Brazil, 2000-2019," published in 2023, in Brazil, Alzheimer's disease has become a major health concern since the population is increasingly aging, coupled with the increasing mortality rates and the growing prevalence of the disease in the country. During 2009-2019, there was a 49% increase in deaths due to Alzheimer's disease in the country, making it the seventh leading cause of death. More than 211,600 deaths were due to the disease in the same period in Brazil. Furthermore, 73% of the deaths were of people aged 80 and above, and 27% were in the 60-79 age group. Thus, the above-mentioned factors are expected to increase the demand for DBS devices for the treatment of diseases in the country in the coming years.
South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Deep Brain Simulation Market Segmentation
The South & Central America deep brain simulation market is segmented into product, application, end user, and country.
Based on product, the South & Central America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the South & Central America deep brain simulation market.
Based on application, the South & Central America deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. In 2022, the Parkinson's disease segment registered the largest share in the South & Central America deep brain simulation market.
Based on end user, the South & Central America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the South & Central America deep brain simulation market.
Based on country, the South & Central America deep brain simulation market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil registered the largest share in the South & Central America deep brain simulation market.
Abbott, Medtronic, Boston Sci, and Leva Nova are some of the leading companies operating in the South & Central America deep brain simulation market.